{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:36:17Z","timestamp":1792503377531,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009076","name":"University of Science and Technology of China","doi-asserted-by":"publisher","award":["KY9100000023"],"award-info":[{"award-number":["KY9100000023"]}],"id":[{"id":"10.13039\/501100009076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000333"],"award-info":[{"award-number":["82000333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470334"],"award-info":[{"award-number":["82470334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.redox.2026.104228","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:52:53Z","timestamp":1779259973000},"page":"104228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Advanced glycation end-products exacerbate myocardial ischemia\/reperfusion injury by promoting mitochondrial oxidative damage and PANoptosis in diabetes mellitus"],"prefix":"10.1016","volume":"94","author":[{"given":"Ji'e","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingpu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiweng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6170-3688","authenticated-orcid":false,"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.redox.2026.104228_bib1","first-page":"e771","article-title":"ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.redox.2026.104228_bib2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"22","key":"10.1016\/j.redox.2026.104228_bib3","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.jacc.2024.02.056","article-title":"Reperfusion injury in patients with acute myocardial infarction: JACC scientific statement","volume":"83","author":"Welt","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.redox.2026.104228_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.redox.2026.104228_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCULATIONAHA.122.061983","article-title":"Coronary artery lesion lipid content and plaque burden in diabetic and nondiabetic patients: prospect II","volume":"147","author":"Gyldenkerne","year":"2023","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.redox.2026.104228_bib6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.redox.2026.104228_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.redox.2026.104228_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12933-024-02403-y","article-title":"An observational study of therapeutic procedures and in-hospital outcomes among patients admitted for acute myocardial infarction in Spain, 2016-2022: the role of diabetes mellitus","volume":"23","author":"De-Miguel-Yanes","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"7","key":"10.1016\/j.redox.2026.104228_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and mortality following acute coronary syndromes","volume":"298","author":"Donahoe","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.redox.2026.104228_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.11.003","article-title":"Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction","volume":"47","author":"Schmitt","year":"2021","journal-title":"Diabetes Metab."},{"issue":"11","key":"10.1016\/j.redox.2026.104228_bib11","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/cvr\/cvae142","article-title":"Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes","volume":"120","author":"Kufazvinei","year":"2024","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.redox.2026.104228_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.redox.2026.104228_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid","year":"2022","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.redox.2026.104228_bib14","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/cells11081312","article-title":"Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs","volume":"11","author":"Twarda-Clapa","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.redox.2026.104228_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tem.2022.11.004","article-title":"Advanced glycation endproducts in diabetes-related macrovascular complications: focus on methylglyoxal","volume":"34","author":"Schalkwijk","year":"2023","journal-title":"Trends Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.redox.2026.104228_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molmed.2023.10.001","article-title":"Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes","volume":"30","author":"Pandeya","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.redox.2026.104228_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.13279","article-title":"PANoptosis: mechanisms, biology, and role in disease","volume":"321","author":"Sun","year":"2024","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.redox.2026.104228_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41419-023-06370-2","article-title":"Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"15","key":"10.1016\/j.redox.2026.104228_bib19","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1016\/j.cell.2024.05.034","article-title":"NLRC5 senses NAD(+) depletion, forming a PANoptosome and driving PANoptosis and inflammation","volume":"187","author":"Sundaram","year":"2024","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.redox.2026.104228_bib20","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.cell.2023.05.005","article-title":"NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs","volume":"186","author":"Sundaram","year":"2023","journal-title":"Cell"},{"issue":"7876","key":"10.1016\/j.redox.2026.104228_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","article-title":"AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence","volume":"597","author":"Lee","year":"2021","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.redox.2026.104228_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.tips.2024.06.002","article-title":"PANoptosis: a novel target for cardiovascular diseases","volume":"45","author":"Xiang","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"14","key":"10.1016\/j.redox.2026.104228_bib23","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/01.CIR.0000143376.64970.4A","article-title":"Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction","volume":"110","author":"Carrabba","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.redox.2026.104228_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/antiox8090344","article-title":"How does pyridoxamine inhibit the formation of advanced glycation end products? The role of its primary antioxidant activity","volume":"8","author":"Ramis","year":"2019","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.redox.2026.104228_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000108104","article-title":"Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy","volume":"27","author":"Williams","year":"2007","journal-title":"Am. J. Nephrol."},{"issue":"22","key":"10.1016\/j.redox.2026.104228_bib26","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.redox.2026.104228_bib27","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.redox.2026.104228_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12933-022-01655-w","article-title":"Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction","volume":"21","author":"Baviera","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"6","key":"10.1016\/j.redox.2026.104228_bib29","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jtcvs.2025.01.020","article-title":"Preoperative diabetes duration and long-term outcomes in patients with acute myocardial infarction undergoing coronary artery bypass grafting","volume":"170","author":"Lee","year":"2025","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"10146","key":"10.1016\/j.redox.2026.104228_bib30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.redox.2026.104228_bib31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomized trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"15","key":"10.1016\/j.redox.2026.104228_bib32","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/nu14153086","article-title":"Advanced glycation end products and their effect on vascular complications in type 2 diabetes mellitus","volume":"14","author":"Lee","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.redox.2026.104228_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6809703","article-title":"The role of AGE\/RAGE signaling in diabetes-mediated vascular calcification","volume":"2016","author":"Kay","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.redox.2026.104228_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104879","article-title":"Vitamin d and advanced glycation end products and their receptors","volume":"158","author":"Kheirouri","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.redox.2026.104228_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s12276-021-00561-7","article-title":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","volume":"53","author":"Rungratanawanich","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.redox.2026.104228_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.redox.2026.104228_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.redox.2016.10.003","article-title":"Nrf2 mediates redox adaptations to exercise","volume":"10","author":"Done","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104228_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.arr.2015.12.005","article-title":"Nrf2 signaling and redox homeostasis in the aging heart: a potential target to prevent cardiovascular diseases?","volume":"26","author":"Silva-Palacios","year":"2016","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.redox.2026.104228_bib39","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI79735","article-title":"Nrf2 promotes neuronal survival in neurodegeneration and acute nerve damage","volume":"125","author":"Xiong","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.redox.2026.104228_bib40","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1073\/pnas.051627098","article-title":"Increased mitochondrial oxidative stress in the sod2 (+\/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis","volume":"98","author":"Kokoszka","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.redox.2026.104228_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101716","article-title":"Epigenetic regulation of mir-29a\/mir-30c\/dnmt3a axis controls sod2 and mitochondrial oxidative stress in human mesenchymal stem cells","volume":"37","author":"Jung","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104228_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41392-025-02255-2","article-title":"Arginase 1 drives mitochondrial cristae remodeling and panoptosis in ischemia\/hypoxia-induced vascular dysfunction","volume":"10","author":"She","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.redox.2026.104228_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2026.02.023","article-title":"Mitochondrial oxidative stress to panoptosis: current evidence and therapeutic implications for neurological diseases","author":"He","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.redox.2026.104228_bib44","article-title":"Mitochondrial dysfunction drives zbp1-mediated panoptosis to increase the susceptibility of heart failure with preserved ejection fraction-associated atrial fibrillation","author":"Duan","year":"2025","journal-title":"J. Adv. Res."},{"issue":"2","key":"10.1016\/j.redox.2026.104228_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/eurheartj\/ehz621","article-title":"Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the empa-reg outcome\u00ae trial","volume":"41","author":"Fitchett","year":"2020","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.redox.2026.104228_bib46","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/cvr\/cvad157","article-title":"Empagliflozin improves cardiac energetics during ischaemia\/reperfusion by directly increasing cardiac ketone utilization","volume":"119","author":"Chase","year":"2023","journal-title":"Cardiovasc. Res."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:56:43Z","timestamp":1783151803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726002260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["S2213231726002260"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104228","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced glycation end-products exacerbate myocardial ischemia\/reperfusion injury by promoting mitochondrial oxidative damage and PANoptosis in diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104228"}}